When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
CRDF - Cardiff Oncology's onvansertib shows sustained clinical benefit in colorectal cancer
Cardiff Oncology Inc.
Cardiff Oncology rises (CRDF+24.4%) on clinical data that further demonstrates the safety, efficacy and durability of response of onvansertib in KRAS-mutated metastatic colorectal cancer (mCRC). Data were presented at the European Society of Medical Oncology Virtual Congress.
More news on: Cardiff Oncology, Inc., Healthcare stocks news, Stocks on the move,